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Swiss tertiary care center experience challenges the age-cohort
effect in Helicobacter Pylori infection
Abstract
BACKGROUND. The epidemiology of Helicobacter pylori infection reflects the age-characteristics,
developmental status and access to health care of the population in a given area. AIM: To assess the
influence of demographic variables on the prevalence of H. pylori status among patients evaluated in a
Swiss university medical center. METHODS. Demographic data (i.e. age, gender, place of birth),
indication for H. pylori testing, history of prior H. pylori eradication therapy, medical field and clinical
setting of the referring physician were reviewed from patient's charts. H. pylori status was assessed by
the 13C Urea breath test. RESULTS. Patients born in Switzerland had lower rates of positive 13C Urea
breath test results compared to those born outside of the country (12/101 [11.9%] vs. 67/252 [26.6%];
p=0.003). While there were no differences between males and females (p>0.05), patients 50 years and
below were more likely to have a positive test result compared to those above the age of 50 years
(59/106 [28.6%] vs. 20/147 [13.6%]; p<0.01). There were no major differences in the rate of positive
13C Urea breath tests in patients with previous history of H. pylori eradication and those without.
Patients with dyspeptic symptoms and those without had similar rates of positive tests (11/61 [18.0%]
vs. 68/292 [23.3%]; p=ns). CONCLUSION. Epidemiologic characteristics of H. pylori infection in
Western countries are influenced by changing demographics. Further studies are warranted to
investigate reasons for the changing trends in the prevalence of H. pylori infection.
Received: 06.08.2008  Accepted: 10.11.2008
J Gastrointestin Liver Dis
December 2008 Vol.17 No 4, 
Address for correspondence: Radu Tutuian, MD
 University Hospital Zurich
 Division of Gastroenterology and  
 Hepatology, Ramistrasse 100
 CH-8091 Zurich, Switzerland
 E-mail: radu.tutuian@access.uzh.ch
ORIGINAL PAPER
Swiss Tertiary Care Center Experience Challenges the Age-
Cohort Effect in Helicobacter Pylori Infection
Damian Gruber, Daniel Pohl, Stephan Vavricka, Bernadette Stutz, Michael Fried, Radu Tutuian
Division of Gastroenterology and Hepatology, Department of Internal Medicine, University Hospital Zurich, Zurich, 
Switzerland
Abstract
Background:The epidemiology of Helicobacter pylori 
infection reﬂects the age-characteristics, developmental
status and access to health care of the population in a given 
area. Aim: To assess the inﬂuence of demographic variables
on the prevalence of H. pylori status among patients evaluated 
in a Swiss university medical center. Methods: Demographic 
data (i.e. age, gender, place of birth), indication for H. 
pylori testing, history of prior H. pylori eradication therapy, 
medical ﬁeld and clinical setting of the referring physician
were reviewed from patient’s charts. H. pylori status was 
assessed by the 13C Urea breath test. Results: Patients born 
in Switzerland had lower rates of positive 13C Urea breath test 
results compared to those born outside of the country (12/101 
[11.9%] vs. 67/252 [26.6%]; p=0.003). While there were no 
differences between males and females (p>0.05), patients 
50 years and below were more likely to have a positive test 
result compared to those above the age of 50 years (59/106 
[28.6%] vs. 20/147 [13.6%]; p<0.01). There were no major 
differences in the rate of positive 13C Urea breath tests in 
patients with previous history of H. pylori eradication and 
those without. Patients with dyspeptic symptoms and those 
without had similar rates of positive tests (11/61 [18.0%] 
vs. 68/292 [23.3%]; p=ns). Conclusion: Epidemiologic 
characteristics of H. pylori infection in Western Countries 
are inﬂuenced by changing demographics. Further studies
are warranted to investigate reasons for the changing trends 
in the prevalence of H. pylori infection.
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Introduction
Helicobacter pylori (H. pylori) is one of the most 
common human pathogens. Worldwide more than half of 
the population is colonized with this gram-negative spiral 
bacterium [1]. In developing countries including Eastern 
Europe the prevalence is as high as 80-90%. Unless 
eradicated, colonization usually persists lifelong increasing 
the risk of developing gastric cancer. In the Western world 
gastric colonization with H. pylori is decreasing presumably 
as a result of better hygienic standards and active eradication 
therapy [2, 3]. 
Infection with H. pylori frequently leads to histologic 
gastritis, but only few of the infected individuals develop 
clinical symptoms of this colonization. Therefore, 
contradictory evidence on the association between epigastric 
symptoms in the absence of structural lesions (i.e. non-
ulcer dyspepsia) and H. pylori comes to no surprise [4]. 
Nevertheless, H. pylori infection plays a role in the 
pathogenesis of chronic active gastritis, peptic ulcer disease, 
gastric mucosa-associated lymphoid tissue lymphoma and 
gastric cancer [2, 5]. In addition several extraintestinal 
conditions have been associated with H. pylori  including 
coronary heart disease, dermatological, rheumatological, 
hematological and neurological disorders [6-8]. Pathogenic 
mechanisms of extra-gastrointestinal manifestiations 
include accelerating atherosclerosis, chronic low-grade 
activation of the coagulation cascade and antigenic mimicry 
between H. pylori and host epitopes causing autoimmune 
disorders [9]. Although the linkage between H. pylori and 
extra-gastrointestinal manifestiations is debated in clinical 
practice, H. pylori testing is requested for many of the above 
mentioned indications. 
There are various factors inﬂuencing the prevalence of
H. pylori infection. While there are no gender differences 
in the prevalence of H. pylori infection, studies indicate an 
increase in the prevalence of GERD with increasing age, 
non-Caucasian race and low socio-economic status [10, 11]. 
With regards to the inﬂuence of age, Graham et al reported
an increase with age at 1%/year in the general population. On 
the other hand, living in developed countries with improved 
2 Gruber et al
hygienic conditions has been shown to decrease the incidence 
of H. pylori infection [12]. As people living in improved 
hygienic condition are advancing in age, it becomes unclear 
how the interaction between these factors impact on the 
prevalence of H. pylori infection.
Several diagnostic methods are available for detecting 
H. pylori infection. Histological examination with culture 
for H. pylori is considered the gold standard for diagnosis 
of gastric colonization. While this approach is not always 
practicable in clinical settings, other tests have been 
developed. Rapid urease test of gastric biopsies has high 
sensitivity and speciﬁcity but implies an endoscopic
examination. Non-invasive tests for the detection of H. 
pylori infection include urea breath test, stool antigen assays 
and serology [13, 14]. Among these, the urea breath test is 
the most frequently used test in clinical setting and, with 
sensitivities and speciﬁcities >95% compared to H. pylori
culture it is considered the gold-standard of the non invasive 
tests [15]. At our institution 13C breath tests are performed 
in the gastrointestinal function laboratory and according to 
an open-access policy the indication for H. pylori testing is 
set by the referring physician. 
Given the limited information on the prevalence of H. 
pylori infection in certain subgroups of patients we performed 
an exploratory study on the inﬂuence of age, gender, place
of birth and indication for testing on the results of H. pylori 
testing at the tertiary care center in Zurich, Switzerland.
Materials and methods
Patient population
In the current study we included data from patients 
referred for H. pylori breath testing to our laboratory between 
January 2002 and December 2006. Permission to review 
medical records was obtained from the Ethics Committee 
of the Canton of Zurich. We excluded patients unable to 
complete the H. pylori breath test, studies aborted due to 
technical failures and datasets with insufﬁcient clinical
information on the indication for testing. We reviewed 
patient charts for demographic data (i.e. age, gender, place 
of birth), indication for H. pylori testing, history of prior 
H. pylori eradication, medical ﬁeld (i.e. internal medicine,
gastroenterology, dermatology, etc.) and clinical setting (i.e. 
private practice, hospital setting) of the referring physician 
in order to determine predictors for a positive H. pylori 
breath test. For the purpose of this study patients born in 
Switzerland were labeled “Swiss” while patients born outside 
of Switzerland were labeled “Non-Swiss”. 
Urea-breath test
Urea breath tests for H. pylori were performed using 
the BreathID® breath monitoring system with the Oridion 
Idkit-hpTM test kit (BreathID Inc. Jerusalem, Israel) and a 
100mg 13C urea tablet (Medical Instruments Corporation, 
Solothurn, Switzerland). The patients were requested to 
come fasted for at least 4 hours prior to the test. After 
Fig 1. H. pylori breath test results. The test was considered positive (a) if the 13CO
2
/12CO
2
 ratio change over baseline 
increased and remained above 5‰. A short increase above 5‰ with subsequent values below this threshold (b) were 
indicative of the presence of urease positive oral ﬂora. The test was considered negative (c) if the 13CO
2
/12CO
2
 ratio 
change over baseline remained below 5‰.
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dissolving the tablet into solution patients drank the 13C 
marked urea and were connected to breath monitoring 
system. The BreathID® system contains an analyzer that 
measures the ratio of 13CO
2
:12CO
2
 in the exhaled air by 
molecular correlation spectrometry. The system continuously 
samples the subject’s breath via a nasal cannula connected to 
the analyzer. 13CO
2
/12CO
2
 ratios are expressed as delta over 
baseline and results are recorded graphically on a monitor 
online and available in real time. The ratio between 13CO
2 
and 12CO
2
 was monitored over 15 minutes. A persistent rise 
of the ratio above 5‰ indicated a positive test, a transitional 
rise with a ﬁnal value below 5‰ indicated urease positive
oral ﬂora (i.e. negative test) while no increase above the
mentioned threshold was considered a negative test (Fig. 
1). Patients were not required to wash their mouths before 
undergoing urea breath testing. 
Statistical analysis 
For this is a cross-sectional study evaluating the 
prevalence of H. pylori infection in the referred population, 
descriptive statistics were used to report prevalence data. 
Differences between proportions were compared using 
Chi-square or Fisher-exact tests. Continuous variables 
were compared using Student t-test or Mann-Whitney U-
test depending on the distribution of data. For statistical 
signiﬁcance alpha was set at 0.05.
Results
Between January 2002 and December 2006, in the 
Gastroenterology Division of the University Hospital of 
Zurich 398 13C urea breath tests were performed (93 positive, 
305 negative [including 56 patients with urease positive oral 
ﬂora] test results) in 353 patients (198 women, mean age 47
years, range 18-85 years). Out of the 353 patients, 314 patients 
underwent one, 33 patients had two and 6 patients had three 
urea breath tests. The initial breath test was positive in 79/353 
(22.3%) patients. Similar proportions of females and males 
tested positive (42/198 [21.2%] vs. 37/155 [23.9%]; p=ns). 
Most referrals for 13C urea breath test came from general 
internal medicine (61.3% patients), gastroenterology (30.1% 
patients) and dermatology (6.4% patients). The proportions 
of patients with a positive H. pylori breath test were similar 
(p=ns) in the groups of patients referred by general internists 
(45/212; 21.2%), gastroenterologists (28/104; 26.9%) and 
dermatologists (4/22; 18.2%). 
Inﬂuence of age and country of origin on the result
of the 13C urea breath test
A larger proportion of patients born outside Switerzland 
(“Non-Swiss”) tested positive (p<0.01) compared to “Swiss” 
patients (Fig. 2). Also the proportion of H. pylori positive 
patients was higher (p<0.01) in patients younger than 50 
years compared to those 50 year and above (Fig. 3a). When 
separating patients into Swiss (Fig. 3b) and Non-Swiss (Fig. 
3c) patients we found a higher prevalence of positive tests in 
patients younger than 50 years (statistically signiﬁcant for
the Non-Swiss sub-population but, due to the low numbers, 
not signiﬁcant for the Swiss sub-population). The highest
rate of H. pylori positive results was noted in “Non-Swiss” 
individuals younger than 50 years (52/165 [31.5%]), the 
lowest rate in “Swiss” patients older than 50 years (5/60 
[8.3%]).
Indication for H. pylori testing 
With regards to the indication for H. pylori testing, we 
focused the analysis on three groups of patients: patients with 
previous history of H. pylori eradication (i.e. veriﬁcation of
successful eradication), patients with dyspeptic symptoms 
and patients referred by dermatologists for evaluation of H. 
pylori status as a cause of urticaria.
Among patients with history of eradication therapy 
22.0% (46/207) tested positive. In the group of patients 
without history of H. pylori eradication 33/146 (22.6%) 
patients also tested positive (p=ns). The 13C urea breath test 
was positive in 18% (11/61) of patients referred for dyspeptic 
symptoms and 23.3% (68/292) of patients without history 
of dyspeptic symptoms (p=ns).
Out of the 19 patients referred for 13C urea breath test as 
part of the work-up for urticaria three (15.8%) tested positive, 
while 76/334 (22.8%) patients without urticaria also tested 
positive (p=ns). 
Discussion
In the present study we found a decrease in the prevalence 
of positive H. pylori breath tests with age, higher rates of 
positive 13C urea breath tests in Non-Swiss patients compared 
to those born in Switzerland and no differences in H. pylori 
positivity with respect to gender, history of prior H. pylori 
eradication and indication for testing. While the results 
on the prevalence of H. pylori status related to the place 
of birth and gender are consistent with previous reports, 
the decreasing prevalence with age contradicts previous 
reports indicating an increased prevalence of H. pylori 
infection with age [2, 12, 16]. The decreasing prevalence 
of positive H. pylori breath test results in our population 
could be due to a referral bias. Patients under the age of 50 
years migrating into Switzerland have a prevalence of H. 
pylori colonization similar to their country of origin whereas 
Fig 2. Prevalence of H. pylori positive patients 
originally from Switzerland (Swiss) and outside the 
country (non-Swiss).
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patients over the age of 50 years from Switzerland were more 
likely to have received antibiotics. In addition, given current 
clinical practice for patients with upper gastrointestinal (GI) 
symptoms, patients over the age of 50 were more likely to 
have had an upper GI endoscopy including H. pylori biopsy 
and would have undergone eradication by the time of the 
breath test. Given the retrospective nature of our study we 
were not able to accurately assess this but current results 
provide the basis for future studies speciﬁcally designed to
investigate the relationship between age and H. pylori status 
in industrialized countries. 
Evaluating the prevalence and risk factors of H. pylori 
infection in Swiss adolescents, Heuberger et al [17] found 
one of the lowest H. pylori infection rates in Europe (9.7%). 
They also observed a signiﬁcant disparity between the rate
of H. pylori infection in the native population (13/176 
[7.3%]) and the subjects from foreign countries (6/20 [30%]). 
Another Swiss study [18] evaluated the prevalence of H. 
pylori infection in 432 randomly selected asymptomatic 
children between the age of 5 and 7 years living in the 
eastern part of Switzerland. In this population the total 
prevalence of H. pylori infection was low (6.5%) with a 
signiﬁcantly higher rate in children, whose parents had
immigrated to Switzerland (19.2% vs. 3.9%). A study by 
Porsch-Ozcurumez M et al [19] presented similar results in 
675 Germans, 260 Turks born and raised in Germany and 148 
Turks living in Turkey. The proportion of H. pylori positive 
individuals (13.1% in Germans, 30.4% in Turks living in 
Germany and 44.5% in Turks living in Turkey) underscored 
that of the country of origin is an important determinant of the 
H. pylori status. The results of our study with a signiﬁcantly
higher prevalence of positive H. pylori breath test results in 
the group of patients born outside the country compared to 
those born in Switzerland are in line with these ﬁndings. The
demographic details available for the present retrospective 
analysis did not allow us to further sub-categorize the country 
of origin of the non-Swiss patients. As suggested by other 
recent studies, the most likely explanation for differences in 
H. pylori prevalence between industrialized and developing 
countries are better hygienic standards and active eradication 
therapy in the Western hemisphere [2, 3].
Similar prevalence of positive H. pylori breath tests in 
males and females indicate that H. pylori colonisation is not 
gender speciﬁc. Evaluating 485 asymptomatic individuals
in the Houston, Texas area, Graham et al [13] found that H. 
pylori colonisation was present in 52% of these individuals. 
While age, race and socioeconomic status inﬂuenced the
prevalence of H. pylori positivity, there were no gender 
differences in the studied population. Similar results on 
gender similarity were reported from regions with an even 
higher prevalence of H. pylori infection. A recent study [14] 
in 1567 patients from Turkey with various GI complaints 
reported similarly high positive 14C urea breath test results in 
males (67.7%) and females (68.2%) (p=0.865). A population 
based epidemiological study from Sweden [20] comparing 
the prevalence of H. pylori infection in 150 adults with 
and without abdominal symptoms also reported no gender 
differences among the 55 H. pylori positive individuals. In 
summary, the results of our study are consistent with previous 
reports indicating that HP-positivity is not gender related. 
Dyspeptic symptoms are common with a prevalence of 
20-40% of the adult population in the Western hemisphere 
[2]. The role of H. pylori colonization in the pathogenesis of 
dyspepsia and data to support H. pylori testing in dyspeptic 
patients are controversial [21, 22]. In the present study we 
Figs 3a-c. Variation in the prevalence of positive H. pylori test 
results with age in all patients (3a), Swiss patients (3b) and non-
Swiss patients (3c). Patients age 50 and below were more likely to 
have a positive test in all three patient groups compared to patients 
above the age of 50 years. Numbers of patients in each age group 
are indicated in parentheses.
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found similar proportion of positive 13C urea breath test 
results in patients with and without history of dyspeptic 
symptoms. Evaluating 148 randomly selected residents 
of Olmsted County, Minnesota aged 20-50 years (36 with 
dyspepsia, 35 with irritable bowel syndrome without 
dyspepsia and 77 asymptomatic individuals), Locke et al 
[23] found a statistically borderline association (p=0.08) 
between dyspepsia and CagA antibody positivity. A Swiss 
study by Verdú et al [24] comparing the prevalence of chronic 
dyspepsia in individuals from developing countries and 
individuals from industrialized countries found no difference 
between the two groups. In contrast, Nelson et al evaluating 
435 healthy individuals (blood donors) and 102 patients 
in a general medical clinic found that patients were more 
likely to have dyspeptic symptoms and more likely to test 
seropositive for H. pylori compared to healthy individuals 
[25]. A logistic regression analysis of these data found CagA 
seropositivity to be an independent variable associated with 
dyspepsia, allowing the authors to interpret these results as 
supportive of the association between H. pylori infection 
and dyspepsia.
Conclusions
In conclusion, the present data challenge the dogma on 
the increasing prevalence of H. pylori colonization with age. 
This relationship between age and H. pylori status in patients 
from industrialized countries referred to tertiary care centers 
warrants further investigations. 
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